申请人:Genome and Company
公开号:EP3792343A1
公开(公告)日:2021-03-17
The present invention relates to a novel Bifidobacterium bifidum MG731 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Bifidobacterium bifidum MG731 strain of the present invention has effects of inhibiting the proliferation of cancer cells, decreasing the mobility of cancer cells, inhibiting the neoangiogenesis, and increasing the anticancer immune response as well as reducing the expression of inflammatory factors, thereby having effects of preventing or treating cancers or inflammatory diseases. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Bifidobacterium bifidum MG731 strain of the present invention exhibits a better anticancer effect. In addition, the present invention relates to a novel Lactococcus lactis GEN3033 strain and a composition for preventing or treating cancers, comprising the same. Specifically, the Lactococcus lactis GEN3033 strain of the present invention exhibits effects of directly inhibiting the proliferation of cancer cells and enhancing immunity, thereby having effects of preventing or treating cancers. In particular, the strain has an excellent anticancer effect by secreting metabolites having an anticancer effect while being established in the gut. In addition, when used in combination with an anticancer chemotherapeutic agent or an anticancer immunotherapeutic agent, the Lactococcus lactis GEN3033 strain of the present invention exhibits a better anticancer effect.
本发明涉及一种新型双歧杆菌 MG731 菌株和一种预防或治疗癌症的组合物。具体来说,本发明的双歧杆菌 MG731 菌株具有抑制癌细胞增殖、降低癌细胞流动性、抑制新血管生成、增加抗癌免疫反应以及减少炎症因子表达的作用,从而具有预防或治疗癌症或炎症性疾病的效果。此外,本发明的双歧杆菌 MG731 菌株与抗癌化疗药物或抗癌免疫治疗药物联合使用时,抗癌效果更好。此外,本发明还涉及一种新型乳球菌 GEN3033 菌株和一种预防或治疗癌症的组合物。具体而言,本发明的乳球菌 GEN3033 菌株具有直接抑制癌细胞增殖和增强免疫力的作用,从而具有预防或治疗癌症的效果。特别是,该菌株在肠道中生长时,通过分泌具有抗癌作用的代谢物,具有极佳的抗癌效果。此外,当与抗癌化疗剂或抗癌免疫治疗剂联合使用时,本发明的乳球菌 GEN3033 菌株表现出更好的抗癌效果。